Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Polar Capital Biotechnology Class I - Income (USD)

Sell:2,582.92p Buy:2,582.92p Change: 28.04p (1.10%)
Prices as at 2 July 2020
Sell:2,582.92p
Buy:2,582.92p
Change: 28.04p (1.10%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 2 July 2020
Sell:2,582.92p
Buy:2,582.92p
Change: 28.04p (1.10%)
Prices as at 2 July 2020
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Asset Allocation

X-ray asset allocation
Key % Net Assets
International Equities 89.85%
UK Equities 6.07%
Cash and Equiv. 4.07%

Top 10 holdings

Stock name % Weight Country Sector
1 REGENERON PHARMACEUTICALS INC 7.07% United States Pharmaceuticals & Biotechnology
2 VERTEX PHARMACEUTICALS INC 5.29% United States Pharmaceuticals & Biotechnology
3 INCYTE CORP 5.29% United States Pharmaceuticals & Biotechnology
4 ALEXION PHARMACEUTICALS INC 5.19% United States Pharmaceuticals & Biotechnology
5 ARGENX SE 4.61% Belgium Pharmaceuticals & Biotechnology
6 SEATTLE GENETICS INC 3.40% United States Pharmaceuticals & Biotechnology
7 IMMUNOVANT INC 2.77% United States Pharmaceuticals & Biotechnology
8 GENMAB AS 2.66% Denmark Pharmaceuticals & Biotechnology
9 NANOSTRING TECHNOLOGIES INC 2.53% United States Pharmaceuticals & Biotechnology
10 SUMMIT THERAPEUTICS 2.46% United Kingdom Pharmaceuticals & Biotechnology

Where is the fund invested?

UK
Equities
Int'l
Equities
UK
Bonds
Int'l
Bonds
UK
Gilts
Managed Funds Property Other Cash and Equiv. Total
Health Care 6.07% 87.25% 93.32%
Cash and Equiv. 4.07% 4.07%
Non-Classified 2.60% 2.60%
Total 6.07% 89.85% 4.07% 100.00%
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Data as at 31 May 2020. Data provided by FundsLibrary.

Fund Analysis is only available on the desktop version of our website. This can be accessed using a desktop or laptop PC or some larger tablets.

You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account